KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Lam Research (LRCX) EBIAT (2016 - 2026)

Lam Research has reported EBIAT over the past 18 years, most recently at $1.8 billion for Q1 2026.

  • For Q1 2026, EBIAT rose 37.18% year-over-year to $1.8 billion; the TTM value through Mar 2026 reached $6.7 billion, up 44.0%, while the annual FY2025 figure was $5.4 billion, 39.98% up from the prior year.
  • EBIAT for Q1 2026 was $1.8 billion at Lam Research, up from $1.6 billion in the prior quarter.
  • Over five years, EBIAT peaked at $1.8 billion in Q1 2026 and troughed at $802.5 million in Q2 2023.
  • A 5-year average of $1.2 billion and a median of $1.2 billion in 2024 define the central range for EBIAT.
  • Biggest five-year swings in EBIAT: crashed 37.76% in 2023 and later surged 68.59% in 2025.
  • Year by year, EBIAT stood at $1.5 billion in 2022, then crashed by 35.02% to $954.3 million in 2023, then grew by 24.81% to $1.2 billion in 2024, then soared by 33.83% to $1.6 billion in 2025, then increased by 14.52% to $1.8 billion in 2026.
  • Business Quant data shows EBIAT for LRCX at $1.8 billion in Q1 2026, $1.6 billion in Q4 2025, and $1.6 billion in Q3 2025.